Skaergaard's First S-K 1300 Report Lifts Indicated PdEq Ounces 31% for Greenland Mines
GRML sits 22% above its 52-week low of $0.156 on elevated volume (7.6× avg).
Summary
The first S-K 1300 technical report for Skaergaard reveals a 31% increase in Indicated PdEq ounces to 15 million and a 36% grade increase, enhancing the project's economic viability and regulatory standing.
Key Events · Product Development and Regulatory · GRML
-
31% Increase in Indicated PdEq Ounces
The 2026 Mineral Resource Estimate reports 15.00 Moz Indicated PdEq, up from 11.41 Moz in the 2022 estimate, with grade improving 36% to 3.04 g/t.
-
First S-K 1300 Compliant Report
SLR Consulting completed the first S-K 1300 Technical Report Summary for Skaergaard, establishing a U.S. regulatory foundation and enabling advancement to an Initial Assessment.
-
Resource Upgrade Methodology
The upgrade reflects updated metal prices (gold at $3,500/oz) and an improved block model that removes artificial dilution, resulting in a higher-grade, more economically robust resource.
-
Path to Initial Assessment
The S-K 1300 conversion allows the company to proceed to an Initial Assessment, which will evaluate open-pit and underground mining scenarios, with 2026 field program data as key inputs.
Analysis · GRML · Life Sciences
The updated mineral resource estimate materially de-risks the Skaergaard project. A 31% jump in Indicated PdEq ounces to 15 million and a 36% grade increase to 3.04 g/t, driven by higher metal prices and a better geological model, significantly improves the project's economic potential. This S-K 1300 conversion provides a U.S. regulatory foundation, enabling the company to advance to an Initial Assessment. Against a backdrop of recent financial distress and a pending reverse stock split, this technical milestone strengthens the asset's value proposition and supports the company's strategic pivot toward critical minerals.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GRML was trading at $0.19 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.6M. The 52-week trading range was $0.16 to $1.38. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.